Literature DB >> 25745055

In reply.

Dario Baratti1, Shigeki Kusamura1, Claudia Maggi2, Filippo de Braud2, Marcello Deraco1, Maria Di Bartolomeo2, Filippo Pietrantonio2.   

Abstract

Mesh：

Year:  2015        PMID： 25745055      PMCID： PMC4350808          DOI： 10.1634/theoncologist.2014-423

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  7 in total

1.  FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

Authors:  Filippo Pietrantonio; Claudia Maggi; Giuseppe Fanetti; Roberto Iacovelli; Maria Di Bartolomeo; Francesca Ricchini; Marcello Deraco; Federica Perrone; Dario Baratti; Shigeki Kusamura; Elena Tamborini; Alessandra Castano; Paola Valentina Consonni; Ilaria Bossi; Cecilia Gavazzi; Massimo Milione; Giuseppe Pelosi; Filippo de Braud
Journal:  Oncologist       Date:  2014-06-20

2.  Challenges of efficacy assessments in pseudomyxoma peritonea.

Authors:  Michael J Overman; Cathy Eng; Kanwal Raghav; Aurelio Matamoros; Melissa Taggart; Wai Chin Foo; Keith Fournier
Journal:  Oncologist       Date:  2015-03

3.  Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases.

Authors:  Norman J Carr; Jenny Finch; Ian Charles Ilesley; Kandiah Chandrakumaran; Faheez Mohamed; Alex Mirnezami; Tom Cecil; Brendan Moran
Journal:  J Clin Pathol       Date:  2012-06-20       Impact factor: 3.411

4.  Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.

Authors:  Joseph Misdraji; Rhonda K Yantiss; Fiona M Graeme-Cook; Ulysses J Balis; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

5.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

6.  Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.

Authors:  Faheez Mohamed; Sue Gething; Moutaz Haiba; Erwin A Brun; Paul H Sugarbaker
Journal:  J Surg Oncol       Date:  2004-04-01       Impact factor: 3.454

7.  A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

Authors:  A L Farquharson; N Pranesh; G Witham; R Swindell; M B Taylor; A G Renehan; S Rout; M S Wilson; S T O'Dwyer; M P Saunders
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.